InnoTherapy, Inc. announced a private placement of 675,675 shares at an issue price of KRW 7,400 per share for a gross proceeds of KRW 4,999,995,000 on March 13, 2023. The transaction will include participation from returning investor, SCL Healthcare Co., Ltd. for 135,135 shares and new investor, Seoul Clinical Laboratories for 540,540 shares. The transaction is expected to close on March 23, 2023.

The transaction has been approved by the board of directors of the company.